| Literature DB >> 35205287 |
Afsaneh Golkar-Narenji1, Paweł Antosik2, Shelly Nolin1, Marcin Rucinski3, Karol Jopek3, Agnieszka Zok4,5, Jarosław Sobolewski6, Maurycy Jankowski7, Maciej Zdun8, Dorota Bukowska9, Katarzyna Stefańska3, Jędrzej M Jaśkowski9, Hanna Piotrowska-Kempisty8,10, Paul Mozdziak1, Bartosz Kempisty1,2,3,7.
Abstract
Modern science is becoming increasingly committed to environmentally friendly solutions, mitigating the impact of the developing human civilisation on the environment. One of the leading fields aimed at sustainable agriculture is in vitro meat production. Cellular agriculture aims to provide a source of animal-free meat products, which would decrease worldwide nutritional dependency on animal husbandry, thereby reducing the significant impact of this industry on Earth's climate. However, while some studies successfully produced lab-based meat on a small scale, scalability of this approach requires significant optimisation of the methodology in order to ensure its viability on an industrial scale. One of the methodological promises of in vitro meat production is the application of cell suspension-based bioreactors. Hence, this study focused on a complex transcriptomic comparison of adherent undifferentiated, differentiated and suspension-cultured myosatellite cells, aiming to determine the effects of different culture methods on their transcriptome. Modern next-generation sequencing (RNAseq) was used to determine the levels of transcripts in the cultures' cell samples. Then, differential expression and pathway analyses were performed using bionformatical methods. The significantly regulated pathways included: EIF2, mTOR, GP6, integrin and HIFα signalling. Differential regulation of gene expression, as well as significant enrichment and modulation of pathway activity, suggest that suspension culture potentially promotes the ex vivo-associated loss of physiological characteristics and gain of plasticity. Therefore, it seems that suspension cultures, often considered the desired method for in vitro meat production, require further investigation to fully elucidate their effect on myosatellite cells and, therefore, possibly enable their easier scalability to ensure suitability for industrial application.Entities:
Keywords: differentiation; gene markers; satellite cell; signalling pathways
Mesh:
Year: 2022 PMID: 35205287 PMCID: PMC8871586 DOI: 10.3390/genes13020242
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Detailed list of the top 20 most regulated genes (ten up and ten down) from the following comparisons: adherent vs. suspension, adherent differentiated vs. suspension, adherent undifferentiated vs. differentiating. Relevant gene symbols’ gene names, RPKM values of two compared groups, “M” value corresponding to the log2 ratio between two compared conditions (log2(RPKM [first group]/RPKM [second group])), “D” the value difference between conditions (RPKM [group with higher RPKM]—RPKM[group with lower RPKM]) and p-values are shown.
| Adherent vs. Suspension | ||||||
|---|---|---|---|---|---|---|
| Symbol | Description | RPKM (Adherent) | RPKM (Suspension) | M | D | |
|
| calcium voltage-gated channel auxiliary subunit γ 3 | 93.74 | 0.07 | 10.40 | 93.67 | 0.0004 |
|
| Wnt family member 10A | 22.51 | 0.03 | 9.34 | 22.48 | 0.01 |
|
| ADAM metallopeptidase domain 8 | 215.70 | 0.49 | 8.79 | 215.21 | 0.00003 |
|
| carbohydrate sulfotransferase 1 | 15.41 | 0.03 | 8.79 | 15.37 | 0.03 |
|
| myosin light chain 3 | 932.39 | 3.61 | 8.01 | 928.79 | 0.0000001 |
|
| gap junction protein delta 4 | 34.45 | 0.21 | 7.37 | 34.24 | 0.005 |
|
| neuromedin U | 32.12 | 0.21 | 7.27 | 31.91 | 0.006 |
|
| obscurin like cytoskeletal adaptor 1 | 219.66 | 1.53 | 7.17 | 218.13 | 0.00003 |
|
| Wnt family member 7A | 17.79 | 0.14 | 7.00 | 17.66 | 0.02 |
|
| matrix metallopeptidase 27 | 79.04 | 0.62 | 6.98 | 78.42 | 0.0007 |
|
| interferon induced transmembrane protein 5 | 0.16 | 117.07 | −9.49 | 116.90 | 0.0002 |
|
| spondin 2 | 0.54 | 426.83 | −9.62 | 426.29 | 0.0000001 |
|
| cadherin 19 | 0.03 | 24.56 | −9.82 | 24.54 | 0.01 |
|
| dermatopontin | 0.05 | 51.28 | −9.88 | 51.23 | 0.002 |
|
| synuclein α | 0.03 | 29.08 | −10.07 | 29.05 | 0.008 |
|
| chondrolectin | 0.03 | 31.02 | −10.16 | 30.99 | 0.007 |
|
| scavenger receptor class A member 3 | 0.03 | 36.43 | −10.39 | 36.40 | 0.004 |
|
| proteolipid protein 1 | 0.05 | 75.57 | −10.44 | 75.51 | 0.0007 |
|
| C1q and TNF related 2 | 0.05 | 75.98 | −10.45 | 75.93 | 0.0007 |
|
| fibrinogen like 2 | 0.27 | 397.62 | −10.52 | 397.35 | 0.0000001 |
| Differentiating vs. Suspension | ||||||
|
| calcium voltage-gated channel auxiliary subunit γ 3 | 77.22 | 0.07 | 10.12 | 77.15 | 0.0008 |
|
| ADAM metallopeptidase domain 8 | 455.09 | 0.49 | 9.87 | 454.61 | 0.0000001 |
|
| matrix metallopeptidase 13 | 64.49 | 0.14 | 8.86 | 64.35 | 0.001 |
|
| epoxide hydrolase 4 | 13.12 | 0.07 | 7.56 | 13.05 | 0.04 |
|
| R-spondin 4 | 23.03 | 0.14 | 7.37 | 22.89 | 0.01 |
|
| matrix metallopeptidase 27 | 90.79 | 0.62 | 7.18 | 90.16 | 0.0005 |
|
| agg recan | 92.72 | 0.69 | 7.06 | 92.03 | 0.0005 |
|
| phosphoglycerate dehydrogenase | 980.38 | 8.54 | 6.84 | 971.84 | 0.0000001 |
|
| paired related homeobox 2 | 101.80 | 1.18 | 6.43 | 100.62 | 0.0004 |
|
| placental growth factor | 227.74 | 2.91 | 6.29 | 224.83 | 0.00003 |
|
| multimerin 2 | 0.06 | 28.66 | −9.02 | 28.60 | 0.008 |
|
| synuclein α | 0.06 | 29.08 | −9.04 | 29.02 | 0.008 |
|
| matrilin 1 | 0.03 | 17.21 | −9.28 | 17.18 | 0.02 |
|
| regulator of G-protein signaling 5 | 0.11 | 68.98 | −9.28 | 68.87 | 0.001 |
|
| breast carcinoma amplified sequence 1 | 0.17 | 104.16 | −9.29 | 103.99 | 0.0004 |
|
| gap junction protein α 4 | 0.03 | 17.63 | −9.31 | 17.60 | 0.02 |
|
| contactin 1 | 0.06 | 38.58 | −9.44 | 38.53 | 0.004 |
|
| forkhead box J1 | 0.03 | 27.48 | −9.96 | 27.45 | 0.009 |
|
| fibrinogen like 2 | 0.22 | 397.63 | −10.81 | 397.41 | 0.0000001 |
|
| proteolipid protein 1 | 0.03 | 75.57 | −11.41 | 75.54 | 0.0009 |
| Adherent vs. Differentiating | ||||||
|
| opioid binding protein/cell adhesion molecule like | 14.11 | 0.50 | 4.82 | 13.61 | 0.04 |
|
| FAT atypical cadherin 3 | 27.89 | 1.11 | 4.65 | 26.78 | 0.008 |
|
| platelet derived growth factor subunit B | 26.21 | 1.11 | 4.56 | 25.10 | 0.01 |
|
| opticin | 34.67 | 1.66 | 4.38 | 33.01 | 0.005 |
|
| slit guidance ligand 1 | 504.98 | 28.24 | 4.16 | 476.74 | 0.00006 |
|
| plexin A2 | 15.03 | 0.89 | 4.08 | 14.15 | 0.03 |
|
| paired box 7 | 84.54 | 5.26 | 4.01 | 79.28 | 0.0007 |
|
| protein tyrosine phosphatase receptor type Q | 80.53 | 5.04 | 4.00 | 75.49 | 0.0008 |
|
| NHS like 2 | 53.83 | 3.88 | 3.80 | 49.95 | 0.002 |
|
| allograft inflammatory factor 1 like | 84.71 | 6.59 | 3.68 | 78.12 | 0.0008 |
|
| scinderin | 0.11 | 24.97 | −7.85 | 24.86 | 0.01 |
|
| glutamine-fructose-6-phosphate transaminase 2 | 0.38 | 105.42 | −8.12 | 105.04 | 0.0002 |
|
| solute carrier family 1 member 6 | 0.05 | 16.67 | −8.26 | 16.61 | 0.02 |
|
| tetratricopeptide repeat domain 29 | 0.16 | 67.94 | −8.71 | 67.77 | 0.0009 |
|
| spondin 2 | 0.54 | 377.28 | −9.44 | 376.74 | 0.0000001 |
|
| osteoglycin | 0.43 | 546.16 | −10.30 | 545.72 | 0.0000001 |
|
| aldo-keto reductase family 1 member D1 | 0.38 | 480.65 | −10.31 | 480.27 | 0.0000001 |
|
| dermatopontin | 0.05 | 90.36 | −10.70 | 90.31 | 0.0003 |
|
| aggrecan | 0.05 | 92.74 | −10.74 | 92.69 | 0.0003 |
|
| scavenger receptor class A member 3 | 0.03 | 101.21 | −11.87 | 101.19 | 0.0002 |
Figure 1Total gene expression profiles in the following comparisons: adherent undifferentiated vs. suspension-cultured, adherent differentiated vs. suspension, adherent undifferentiated vs. differentiated. Each dot represents log2(RPKM) value from a single gene. Grey dots represent the genes below cut-off limit (p > 0.05). Green and red dots represent differentially expressed genes where green colour marked the stimulated genes, while red ones were inhibited. Stimulation or inhibition was determined in relation to the second group from each compared pair (occurring after vs. in the graph description).
Figure 2Metascape functional analysis of transcriptome profiles between: Adherent differentiated vs. Suspension, Adherent undifferentiated vs. Differentiated, Adherent undifferentiated vs. Suspension. (A) The Venn diagram shows overlapping of DEGs from different input gene lists. (B) Heatmap of the top 20 enriched terms across differentially expressed gene lists.
Figure 3Network of significantly enriched terms obtained by Metascape. Nodes of the network are composed of two circular components. The internal one represents a cluster identified by a generalized name (cluster-ID), coloured by cluster-ID, where nodes sharing the same cluster ID are closer to each other and are marked by this same colour. External components of nodes are colour-coded, corresponding to the DEGs numbers from each comparison.
Figure 4The 20 most statistically significantly enriched ontological terms in the analysed comparisons (A–C). The colour of nodes corresponds to the p-value, and the size of nodes represents the number of genes forming a given ontological group. Graphs were produced using clusterProfiler package.
Figure 5Protein–protein interaction enrichment analysis. Network contains the subset of proteins that form physical interaction with at least one other member from the input list. The Molecular Complex Detection (MCODE) algorithm was applied to identify the density of connected nodules with relevant statistics analysis presented as log10(p) value. Each MCODE network is assigned a unique colour.
Figure 6Bubble plot of differentially expressed gene sets overrepresented in the DAVID GO BP DIRECT gene ontology (GO) database. The analysis was performed separately for each experimental group (Adherent vs. Suspension, Differentiating vs. Suspension, Adherent vs. Differentiating). The graph shows only the GO terms above the established cut-off criteria (p with correction <0.05 and >5 genes per group). Each bubble’s size reflects the number of differentially expressed genes, assigned to the GO BP terms. The bubbles’ transparency displays p-values (more transparent—closer to the p = 0.05 cut-off). The red colour indicates downregulated expression of the genes comprising the relevant GO terms; green colour indicates upregulation.
Figure 7Detailed analysis of seven enriched gene ontology groups selected from the DAVID GO BP DIRECT GO database presented using circos plots. Symbols of DEG from each of the analysed comparisons are displayed on the left side of the graph with their logFC values, mapped by colour scale (green = higher expression; red = lower expression). The grey colour corresponds to expression levels below the cut-off value for the given comparisons. Coloured connecting lines determine gene involvement in the GO terms.
Figure 8Striated Muscle Contraction Pathway. Colours map expression changes of genes; green colour—statistically significant increase in expression, red colour—statistically significant decrease in expression, white colour—statistically insignificant. The box in the pathway that corresponds to a given gene was divided into three parts, coloured separately according to the gene expression comparisons. Graph was produced using Cytoscape (v. 3.7.2) with RCy3 library.